Speaker illustration

Doctor Hiroaki Hiraiwa

Nagoya University Graduate School of Medicine, Nagoya (Japan)

Member of:

European Society of Cardiology

・Member of the Advanced Heart Failure Treatment Center at Nagoya University Hospital, and engaged in clinical and research studies on severe heart failure requiring mechanical circulatory support (ECMO, Impella, VAD, and heart transplantation) ・Conducted several clinical research studies on a wide range of cardiac diseases, including heart failure, fulminant myocarditis, dilated cardiomyopathy; with a publication record of numerous papers in English as first author and as a co-author. ・Extensive research presentation history at numerous domestic and international academic conferences, the recipient of the Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS KAKENHI)

Clinical significance of spleen size in patients with heart failure

Event: ESC Congress 2021 - The Digital Experience

Topic: Haemodynamics of Heart Failure

Session: Chronic heart failure e-posters

Thumbnail

The prognostic impact of right ventricular dysfunction in patients with septic cardiomyopathy

Event: ESC Congress 2020

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Cardiac ITU Is about the Heart, and More

Thumbnail

Associations between spleen volume and exercise capacity in advanced heart failure patients with left ventricular assist device

Event: ESC Congress 2020

Topic: Ventricular Assist Devices

Session: Chronic Heart Failure ePosters

Thumbnail

Splenic volume changes as a hemodynamic parameter in advanced heart failure with left ventricular assist device

Event: ESC Congress 2019

Topic: Haemodynamics of Heart Failure

Session: Stage D heart failure

Thumbnail

The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy

Event: ESC Congress 2017

Topic: Cardiomyopathies

Session: Cardiomyopathy

Thumbnail

The ratio of plasma branched-chain amino acids to aromatic amino acids level is a useful prognostic marker in acute decompensated heart failure patients

Event: ESC Congress 2016

Topic: Heart failure, other

Session: Heart failure/Left ventricular function

Thumbnail